http://www.fpnotebook.com/
Factor Xa Inhibitor
Aka: Factor Xa Inhibitor, FXa Inhibitor
- See Also
- Anticoagulants
- Clotting Pathway
- Class
- Direct Factor Xa Inhibitor
- Factor Xa is the first step in the Common Clotting Cascade
- Mechanism: Based on naturally occurring substances
- Antistasin
- Isolated in 1980s from Mexican leach extract
- Tick Anticoagulant peptide (TAP)
- Isolated from the tick Ornithodoros moubata
- Preparations
- Rivaroxaban (Xarelto)
- Oral Anticoagulant for Atrial Fibrillation as a second line alternative to Warfarin or Dabigatran (Pradaxa)
- Apixaban (Eliquis)
- Oral anticoagluant for Atrial Fibrillation (released in United States in 2013)
- Appears more effective than Warfarin with less risk of bleeding
- Prevents 3 more strokes per 1000 patients per year than Warfarin
- Complications are less than Warfarin including 10 fewer bleeding complications and 4 fewer deaths per 1000 patients per year
- References
- Mohammed (2012) J Cardiovasc Med 13(2):73-85
- Fondaparinux (Arixtra)
- Betrixaban
- Edoxaban
- Otamixaban
- Management: Reversal
- Stop FXa Inhibitor
- Consider Activated Charcoal if presenting within 2 hours of suspected overdose ingestion
- Consider Recombinant activated Clotting Factor VII (rFVIIa) 30-90 mcg/kg (expert opinion)
- Dialysis is not effective (protein bound)